午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

ChemicalBook >> journal list >> ACS Applied Electronic Materials >>article
ACS Applied Electronic Materials

ACS Applied Electronic Materials

IF: 4.29
Download PDF

Escape from human immunodeficiency virus type 1 (HIV-1) entry inhibitors.

Published:1 December 2012 DOI: 10.3390/v4123859 PMID: 23342377
Christopher J De Feo, Carol D Weiss

Abstract

The human immunodeficiency virus (HIV) enters cells through a series of molecular interactions between the HIV envelope protein and cellular receptors, thus providing many opportunities to block infection. Entry inhibitors are currently being used in the clinic, and many more are under development. Unfortunately, as is the case for other classes of antiretroviral drugs that target later steps in the viral life cycle, HIV can become resistant to entry inhibitors. In contrast to inhibitors that block viral enzymes in intracellular compartments, entry inhibitors interfere with the function of the highly variable envelope glycoprotein as it continuously adapts to changing immune pressure and available target cells in the extracellular environment. Consequently, pathways and mechanisms of resistance for entry inhibitors are varied and often involve mutations across the envelope gene. This review provides a broad overview of entry inhibitor resistance mechanisms that inform our understanding of HIV entry and the design of new inhibitors and vaccines.

Substances (6)

Related products
Procduct Name CAS Molecular Formula Supplier Price
HIV-1 10 suppliers Inquiry
pCMV-10A1 Envelope Vector 9 suppliers Inquiry
Envelope protein 6 suppliers Inquiry
HIV Chimeric Protein 4 suppliers Inquiry
Human Immunodeficiency Virus type 1 (HIV-1) p24 ELISA Kit 4 suppliers Inquiry
Envelope glycoprotein 2 suppliers Inquiry

Similar articles

IF:96.2

A preliminary study of ritonavir, an inhibitor of HIV-1 protease, to treat HIV-1 infection.

New England Journal of Medicine M Markowitz, M Saag,etc Published: 7 December 1995
IF:4.9

Pyridine-2,6-Dithiocarboxylic Acid and Its Metal Complexes: New Inhibitors of New Delhi Metallo β-Lactamase-1.

Marine Drugs Chris S Thomas, Doug R Braun,etc Published: 2 June 2020
IF:1.2

Comparison of adjunctive therapy with metformin and acarbose in patients with Type-1 diabetes mellitus.

Pakistan Journal of Medical Sciences Amir Ziaee, Neda Esmailzadehha,etc Published: 1 May 2017